Description

Triombrast (diatrizoic acid dihydrate) solution for injection 60% 20 ml. vials №5

Ingredients

Active ingredient: Diatrizoic acid dihydrate

Dosage

Dosage: The recommended dosage of Triombrast solution for injection is determined by the healthcare provider based on the patient’s condition and medical history.

Indications

Indications: Triombrast is indicated for diagnostic imaging procedures to enhance visibility of internal structures.

Contraindications

Contraindications: Do not use Triombrast if the patient has a known hypersensitivity to diatrizoic acid dihydrate or any other ingredients in the formulation.

Directions

Directions: Triombrast is for intravenous use only. Follow the healthcare provider’s instructions for administration.

Scientific Evidence

Scientific evidence: Studies have shown that diatrizoic acid dihydrate, the active ingredient in Triombrast, effectively enhances contrast in imaging studies, aiding in the accurate diagnosis of various medical conditions.

Additional Information

Storage: Store Triombrast solution for injection as directed on the packaging to maintain stability and efficacy.

Pharmacological Effects: Diatrizoic acid dihydrate works by altering the density of the body tissues, allowing for clearer visualization of the internal structures during imaging procedures. This enhancement in contrast helps healthcare providers to accurately identify and diagnose medical conditions.

Clinical Trials: Clinical trials evaluating the efficacy of Triombrast have demonstrated its superiority in providing high-quality imaging results compared to similar contrast agents. The safety profile of Triombrast was also favorable, with minimal adverse effects reported during the trials.